Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi PEA Asie Emergente (MSCI Emerging Asia) Screened UCITS ETF Acc

PAASI · FR0013412012 · class EUR (C/D) · EUR · domicile France
Equity · Asia-Pacific · Energy · Sustainable / ESGSFDR art. 8
Index tracked: MSCI EM Asia Screened Select ex Thermal Coal Index
TER
0.30%+ trans. 0.00%
Fund size
734 m EUR
Tracking difference
−0.73%3-year avg
🇮🇹 tax rate
white list not published
Replication
Synthetic (swap)
Income
Mixed (acc. and/or dist.)
Launch 25 Apr 2019 · costs from the KID as of 2 Sept 2026 · 54 securities held · 5 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Fund is a passively managed UCITS. The Fund promotes environmental and/or social characteristics within the meaning of Article 8 of the Disclosure Regulation. By subscribing to Amundi PEA Asie Emergente (MSCI Emerging Asia) Screened UCITS ETF, you are investing in a passively managed UCITS whose objective is to replicate as accurately as possible the performance of the MSCI EM Asia Screened Select ex Thermal Coal Index (the "Index"), regardless of whether it experiences a positive or negative development. The maximum tracking error objective between…

Performance since series start (in euro) — base 100

25 Apr 20198 Sept 2026 · dividends reinvested where declared by the issuer
202020212022202320242025202620980200
High 209 (18 Jun 2026) · low 80 (19 Mar 2020) · last 200. Past performance is not indicative of future results.

Returns in euro

1 year+47.7%
3 years+85.6%
5 years+55.3%
10 yearsseries too young
Since series start+99.7%

Risk · 1 / 3 / 5 years

Volatility (ann.)27.00%20.94%20.00%
Max drawdown−16.60%−18.30%−27.55%
Sharpe1.460.930.41
Sortino2.161.320.59
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · PAASI · FR00134120121
RebalixPAASI · FR0013412012 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · declared by the issuer
YearFundIndexTD
2025+21.78%+22.59%−0.80%
2024+16.36%+17.33%−0.97%
2023+1.21%+1.64%−0.43%
2022−16.14%−15.93%−0.21%
2021+1.72%+2.12%−0.40%

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 54 securities · top-10 weight = 54.2%
Top holdingsWeight
ASML HOLDING NV8.8%
AIRBUS SE PARIS7.9%
BE SEMICONDUCTOR INDUSTRIES7.0%
DEUTSCHE BANK AG NAMEN5.4%
NOKIA OYJ HELSINKI4.7%
ING GROEP NV4.4%
BOLIDEN AB4.4%
MERCK KGAA4.0%
ADIDAS AG3.9%
INFINEON TECHNOLOGIES AG3.8%

Listing venues

ESMA register (FIRDS) and official exchange lists
18MB · Börse Hamburg, Börse Hannover, Börse Stuttgart, Tradegate Exchange
PAASI · Euronext Paris
+ 18 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.ch/pdfDocuments/kid-priips/FR0013412012/ENG/CHE
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/FR0013412012/ENG/FRA/I
Prospectus · www.amundietf.ch/pdfDocuments/prospectus/FR0013412012/ENG/CHE
The live sheet, always up to date
rebalix.com/en/etf/FR0013412012
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · PAASI · FR00134120122